MYUNGMOON PharmLtd Dividends and Buybacks
Dividend criteria checks 0/6
MYUNGMOON PharmLtd does not currently pay a dividend.
Key information
0%
Dividend yield
0.4%
Buyback Yield
Total Shareholder Yield | 0.4% |
Future Dividend Yield | n/a |
Dividend Growth | n/a |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | ₩14.142 |
Payout ratio | 0% |
Recent dividend and buyback updates
Recent updates
Health Check: How Prudently Does MYUNGMOON PharmLtd (KRX:017180) Use Debt?
Dec 16Is MYUNGMOON PharmLtd (KRX:017180) Weighed On By Its Debt Load?
Sep 06MYUNGMOON Pharm co.,Ltd's (KRX:017180) 35% Share Price Surge Not Quite Adding Up
Jul 26MYUNGMOON PharmLtd (KRX:017180) Has No Shortage Of Debt
Mar 21Does MYUNGMOON PharmLtd (KRX:017180) Have A Healthy Balance Sheet?
Mar 31Introducing MYUNGMOON PharmLtd (KRX:017180), A Stock That Climbed 77% In The Last Five Years
Feb 06Does Myungmoon Pharm (KRX:017180) Have A Healthy Balance Sheet?
Dec 15Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if A017180's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if A017180's dividend payments have been increasing.
Dividend Yield vs Market
MYUNGMOON PharmLtd Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (A017180) | 0% |
Market Bottom 25% (KR) | 1.2% |
Market Top 25% (KR) | 3.9% |
Industry Average (Pharmaceuticals) | 1.1% |
Analyst forecast (A017180) (up to 3 years) | n/a |
Notable Dividend: Unable to evaluate A017180's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate A017180's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: A017180 is not paying a notable dividend for the KR market.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as A017180 has not reported any payouts.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2024/12/25 01:26 |
End of Day Share Price | 2024/12/24 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
MYUNGMOON Pharm co.,Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|